Analyst Price Target is $13.50
▲ +392.70% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Unicycive Therapeutics in the last 3 months. The average price target is $13.50, with a high forecast of $13.50 and a low forecast of $13.50. The average price target represents a 392.70% upside from the last price of $2.74.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Unicycive Therapeutics.